Abstract
SIGNIFICANCE: There is an unmet need for effective ovarian cancer screening and diagnostic approaches that enable earlier-stage cancer detection and increased overall survival. We have developed a high-performing accessible approach that evaluates cfDNA fragmentomes and protein biomarkers to detect ovarian cancer.
Original language | English |
---|---|
Pages (from-to) | 105-118 |
Number of pages | 14 |
Journal | Cancer discovery |
Volume | 15 |
Issue number | 1 |
DOIs | |
State | Published - Jan 13 2025 |